nice summary & good points. hopefully the French and UK regulatory approval for sale of sentenial will come in soon (est 3-6months from mid March announcement ) so any time now really ... there are still some impairments which are a lot less compared to last year. so an overloss this year is expected... interested more about future guidance... the new management has done everything they have set out to do. with all the dead weight now coming to a conclusion. look forward to the improved reporting news flow. agree with one of the earlier comments, they should consider qtrly updates to help rebuild market confidence and sentiment. maybe if someone gets an opportunity, this could be requested on the 28th. DYOR
nice summary & good points. hopefully the French and UK...
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EML (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
69.5¢ |
Change
-0.010(1.42%) |
Mkt cap ! $260.7M | |||
| Open | High | Low | Value | Volume |
| 70.5¢ | 71.8¢ | 67.5¢ | $2.785M | 4.005M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 17253 | 69.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 70.0¢ | 304 | 1 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| EML (ASX) Chart |